Abstract
The current study included (45) female samples whose ages ranged between (20-40) years. For the period from September to February of the year 2024, the samples were divided into three groups: The group of healthy women: This group included (15) samples of women who did not suffer from polycystic ovary syndrome (PCOS) as a control group, a group of women with the syndrome, and a group Women with endometriosis: This group included (15) women with polycystic ovary syndrome (PCOS) and (15) women with endometriosis. The results of the current study showed that there was a significant change in the level of FSH at the probability level (P≤0.0001) between the patient groups and the healthy group, as its level increased significantly in women with endometriosis (11.619±0.479) and decreased significantly in women patients with PCOS (7.624±0.293). ) compared to its level in the healthy group (9.133±0.247), and it also decreased significantly in women with polycystic ovary syndrome compared to the group with endometriosis.
The statistical results also showed a significant difference in the level of the LH hormone between the groups of patients and the healthy group at the probability level (P≤0.0001), as it showed a significant decrease in women suffering from Endometriosis (1.109±0.318) compared to the healthy group, while its level increased in women with polycystic ovary syndrome (15.815). PCOS (±0.289) compared to its level in the group of healthy people (6.925±0.407) and those with endometriosis (P≤0.0001). Conclusion: Disturbances in the level of sexual and gonadal hormones play a major role in causing the pathological conditions leading to polycystic ovary syndrome and endometriosis.